OTX-TKI Axitinib Implant
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for OTX-TKI Axitinib Implant, covering 2025-04-18 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study [Phase 3]